JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raylman, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raylman, R. R.
Journal of Nuclear Medicine Vol. 42 No. 2 352-360
© 2001 by Society of Nuclear Medicine


BASIC SCIENCE INVESTIGATIONS

Performance of a Dual, Solid-State Intraoperative Probe System with 18F, 99mTc, and 111In

Raymond R. Raylman

Center for Advanced Imaging, Department of Radiology, West Virginia University, Morgantown, West Virginia

The use of tracer-avid radiopharmaceuticals and handheld, intraoperative, radiation-sensitive probes to localize areas of tumors promises to improve surgical treatments of cancer. Currently several ß- and {gamma}-ray-emitting radiopharmaceuticals are proposed for use in these procedures. Therefore, intraoperative-probe systems should be capable of optimum performance with several different radionuclides. The goal of this study was to evaluate the performance of a dual, solid-state probe with three of these radionuclides (18F, 99mTc, and 111In). Methods: The detector unit of the intraoperative-probe system used in this investigation consisted of a stack of two ion-implanted silicon detectors separated by 0.5 mm. The system could be operated in two modes: ß optimized, in which the difference between the signals from the two detectors was calculated to correct the ß signal for photon contamination, and photon-optimized mode, in which the signals were summed. Detection sensitivity and an index measuring ß detection selectivity were measured in both acquisition modes with the three different radionuclides. The {gamma}-ray detection sensitivity of a commercially available probe was measured with 99mTc and compared with the results with a solid-state probe. Results: ß and photon emissions ({gamma}-rays and annihilation photons) produced by all three radionuclides were detected by the probe. In ß-optimized acquisition mode, the greatest ß-detection sensitivity was achieved with 18F; photon sensitivity was greatest for measurements with 111In. The lowest detection sensitivities (ß and photon) were obtained with 99mTc. With the probe system in {gamma}-optimized mode, the greatest ß and photon sensitivities were achieved with 18F; the lowest were obtained with 99mTc. The {gamma}-detection sensitivity measured with 99mTc in {gamma} mode (5.59 ± 0.41 counts per second [cps]/kBq) compared surprisingly well with the results from the commercial probe (8.75 ± 0.47cps/kBq). Conclusion: The results from this investigation demonstrate the flexibility and versatility of the dual, solid-state probe system used in this study. These capabilities may be used to improve existing techniques or lead to new methods for performing radionuclide-guided surgeries.

Key Words: intraoperative probes • radionuclide-guided surgery • cancer







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.